Cetera Investment Advisers’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $736K | Sell |
4,848
-4,816
| -50% | -$731K | ﹤0.01% | 2664 |
|
|
2025
Q1 | $1.45M | Buy |
9,664
+660
| +7% | +$99.3K | ﹤0.01% | 1977 |
|
|
2024
Q4 | $1.66M | Sell |
9,004
-1,099
| -11% | -$203K | ﹤0.01% | 1791 |
|
|
2024
Q3 | $1.99M | Buy |
10,103
+134
| +1% | +$26.4K | ﹤0.01% | 1636 |
|
|
2024
Q2 | $2.06M | Buy |
9,969
+229
| +2% | +$47.3K | ﹤0.01% | 1549 |
|
|
2024
Q1 | $2.64M | Buy |
9,740
+6,728
| +223% | +$1.82M | 0.01% | 1360 |
|
|
2023
Q4 | $712K | Buy |
3,012
+202
| +7% | +$47.8K | 0.01% | 1301 |
|
|
2023
Q3 | $551K | Buy |
2,810
+18
| +0.6% | +$3.53K | ﹤0.01% | 1368 |
|
|
2023
Q2 | $587K | Buy |
2,792
+993
| +55% | +$209K | ﹤0.01% | 1360 |
|
|
2023
Q1 | $363K | Sell |
1,799
-81
| -4% | -$16.3K | ﹤0.01% | 1602 |
|
|
2022
Q4 | $410K | Buy |
1,880
+517
| +38% | +$113K | ﹤0.01% | 1483 |
|
|
2022
Q3 | $268K | Sell |
1,363
-115
| -8% | -$22.6K | 0.01% | 1349 |
|
|
2022
Q2 | $316K | Buy |
1,478
+57
| +4% | +$12.2K | 0.01% | 1383 |
|
|
2022
Q1 | $404K | Sell |
1,421
-1,212
| -46% | -$345K | 0.01% | 1303 |
|
|
2021
Q4 | $992K | Sell |
2,633
-219
| -8% | -$82.5K | 0.01% | 807 |
|
|
2021
Q3 | $1.18M | Sell |
2,852
-21
| -0.7% | -$8.67K | 0.02% | 717 |
|
|
2021
Q2 | $1.06M | Buy |
2,873
+1,081
| +60% | +$400K | 0.02% | 751 |
|
|
2021
Q1 | $519K | Buy |
1,792
+63
| +4% | +$18.2K | 0.01% | 960 |
|
|
2020
Q4 | $432K | Buy |
+1,729
| New | +$432K | 0.01% | 1030 |
|